학술논문
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
Document Type
Article
Author
Robidoux, André; Tang, Gong; Rastogi, Priya; Geyer, Charles E, Jr; Azar, Catherine A; Atkins, James N; Fehrenbacher, Louis; Bear, Harry D; Baez-Diaz, Louis; Sarwar, Shakir; Margolese, Richard G; Farrar, William B; Brufsky, Adam M; Shibata, Henry R; Bandos, Hanna; Paik, Soonmyung; Costantino, Joseph P; Swain, Sandra M; Mamounas, Eleftherios P; Wolmark, Norman
Source
In Lancet Oncology November 2013 14(12):1183-1192
Subject
Language
ISSN
1470-2045